Drug intelligence / Profile preview

(1S,4R,7AR)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the molecular formula C17H27NO4 and a molecular weight of approximately 309.41 g/mol[1][2][9]. It is listed in chemical and drug databases as an experimental or candidate drug but does not have an established clinical use or approved indication. The structure features an isoindole core substituted with butoxy and formylpropyl groups. There is no publicly available information on its mechanism of action or therapeutic target; however it has been referenced as a ligand in protein structural studies[3][8] and appears in patent literature for potential pharmaceutical applications[6]. No evidence suggests it has reached advanced clinical development.

Other names
(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID(1S,4R,7aR)-4-butoxy-1-(2R)-1‑oxobutan‑2‑yl‑2,4,5,6 , 7 , 7a - hexahydro - 1H - isoindole - 3 - carboxylic acid(3S , 3aR , 7 R )‑7-butoxy‑3-(2 R )‑oxobutan ‑2 ‑yl ‑3 , 3 a , 4 , 5 , 6 , 7 ‑hexahydro ‑2 H – isoindole – carboxylic acid

Beyond the preview

Go deeper on (1S,4R,7AR)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1S,4R,7AR)-4-butoxy-1-[(1R)-1-formylpropyl]-2,4,5,6,7,7a-hexahydro-1H-isoindole-3-carboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call